Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Hyperlipidemia.

American Family Physician

|September 1, 1983

Summary

This summary is machine-generated.

Hyperlipidemia affects 10% of U.S. adults, with common types IIa, IIb, and IV. Treatment varies by phenotype, using anion-exchange resins, gemfibrozil, or clofibrate for effective lipid management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Aminoglycosides: once-daily dosing regimen.

American family physician·1996

Same author

Principles of drug therapy in geriatric patients.

American family physician·1992

Same author

Alternative first-line therapies in geriatric hypertension.

Geriatrics·1989

Same author

Atrial fibrillation.

The Journal of family practice·1986

Same author

Digitalis glycosides.

American family physician·1983

Same author

Type I Hyperlipidemia.

American family physician·1983

Same journal

For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

American family physician·2026

Same journal

Nausea and Vomiting During Pregnancy.

American family physician·2026

Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

American family physician·2026

Same journal

Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

American family physician·2026

Same journal

Overscreening Leads to Overdiagnosis of MASLD.

American family physician·2026

Same journal

Type 2 Diabetes: Outpatient Insulin Management.

American family physician·2026

See all related articles

Area of Science:

Cardiology
Metabolic Disorders
Pharmacology

Background:

Hyperlipidemia impacts 10% of the US population.
Commonly observed phenotypes include Type IIa, Type IIb, and Type IV hyperlipidemias.
Effective management requires a comprehensive clinical evaluation.

Purpose of the Study:

To outline the pharmacological approaches for managing different hyperlipidemia phenotypes.
To emphasize the importance of a holistic approach in treating lipid disorders.

Main Methods:

Review of current therapeutic guidelines for hyperlipidemia.
Categorization of treatments based on hyperlipidemia types (e.g., hypercholesterolemia, hypertriglyceridemia).
Inclusion of diagnostic evaluation components such as genetic factors, lipid profiles, and serum examination.

Related Experiment Videos

Main Results:

Anion-exchange resins are primary for hypercholesterolemia (Type IIa).
Gemfibrozil is indicated for massive hypertriglyceridemia (often associated with Type IV).
Clofibrate is the recommended treatment for Type III hyperlipidemia.

Conclusions:

Tailored pharmacological interventions are crucial for specific hyperlipidemia phenotypes.
A thorough patient assessment, encompassing genetics and biochemical markers, is fundamental for successful management.
Understanding lipid profiles guides the selection of appropriate lipid-lowering agents.